Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Microbiol Res. 2023 Jan;266:127245. doi: 10.1016/j.micres.2022.127245. Epub 2022 Oct 28.
Numerous studies have almost proven the beneficial effects of gut microbiota in various aspects of human health, and even the gut microbiota is known as a new and forgotten organ. Akkermansia muciniphila, as a member of the gut microbiota, is considered a bacterium with probiotic properties; consequently, it has a remarkable position in microbiome research. This bacterium accounts for about 1-4 % of the total fecal microbiota population and is also considered a health marker. The accumulated evidence has shown a significant association between A. muciniphila and several disorders and diseases, such as obesity, fatty liver disease, diabetes, and even behavioral disorders. On the other hand, the beneficial effects of A. muciniphila in different studies have shown, such as protective role against pathogenic agents, antitumor properties, tight junctions' improvement, reduction of inflammation, gut permeability, and boosting adaptive immune responses. In this review, based on the available evidence and the latest research, we comprehensively evaluated the impact of A. muciniphila on host health from three points of view: metabolic, protective, and immune functions, as well as the possible mechanisms of each process.
大量研究几乎证明了肠道微生物群在人类健康的各个方面的有益作用,甚至肠道微生物群被称为新的被遗忘的器官。黏蛋白阿克曼菌作为肠道微生物群的一员,被认为是一种具有益生菌特性的细菌;因此,它在微生物组研究中占有显著地位。这种细菌占粪便微生物群总数的 1-4%,也被认为是健康标志物。积累的证据表明,黏蛋白阿克曼菌与多种疾病和病症之间存在显著关联,如肥胖、脂肪肝疾病、糖尿病,甚至行为障碍。另一方面,不同研究中黏蛋白阿克曼菌的有益作用表明,如对病原体的保护作用、抗肿瘤特性、改善紧密连接、减少炎症、肠道通透性和增强适应性免疫反应。在这篇综述中,根据现有的证据和最新的研究,我们从代谢、保护和免疫功能三个方面全面评估了黏蛋白阿克曼菌对宿主健康的影响,以及每个过程的可能机制。